Globe Life Inc. $GL Shares Acquired by Pzena Investment Management LLC

Pzena Investment Management LLC lifted its stake in shares of Globe Life Inc. (NYSE:GL) by 5.6% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 998,506 shares of the company’s stock after purchasing an additional 52,523 shares during the period. Pzena Investment Management LLC owned about 1.23% of Globe Life worth $142,756,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the company. Synergy Asset Management LLC increased its holdings in shares of Globe Life by 1,022.7% in the 3rd quarter. Synergy Asset Management LLC now owns 100,603 shares of the company’s stock worth $14,240,000 after acquiring an additional 91,642 shares during the period. Allianz Asset Management GmbH grew its position in Globe Life by 55.2% in the 3rd quarter. Allianz Asset Management GmbH now owns 82,263 shares of the company’s stock worth $11,761,000 after purchasing an additional 29,256 shares during the last quarter. SteelPeak Wealth LLC acquired a new stake in shares of Globe Life in the third quarter valued at approximately $2,985,000. Retirement Systems of Alabama bought a new stake in shares of Globe Life during the third quarter valued at approximately $2,470,000. Finally, MGO One Seven LLC acquired a new position in shares of Globe Life during the third quarter worth approximately $1,364,000. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

GL has been the topic of several analyst reports. TD Cowen restated a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. JPMorgan Chase & Co. lifted their price objective on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Wells Fargo & Company decreased their target price on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a research report on Friday, October 24th. Morgan Stanley reissued an “overweight” rating and set a $176.00 target price on shares of Globe Life in a research note on Monday, December 15th. Finally, Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, February 13th. Eight analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $171.22.

Globe Life Stock Performance

NYSE:GL opened at $143.79 on Thursday. The firm has a market capitalization of $11.45 billion, a PE ratio of 10.21 and a beta of 0.47. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life Inc. has a 12-month low of $109.38 and a 12-month high of $152.71. The firm has a 50-day moving average price of $141.23 and a 200 day moving average price of $138.52.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The company had revenue of $1.52 billion during the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter in the prior year, the company posted $3.14 earnings per share. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Research analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Mark A. Blinn sold 1,750 shares of the stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $147.91, for a total transaction of $258,842.50. Following the completion of the sale, the director owned 3,372 shares in the company, valued at $498,752.52. This trade represents a 34.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael Clay Majors sold 30,000 shares of the business’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $146.89, for a total transaction of $4,406,700.00. Following the completion of the transaction, the executive vice president owned 47,066 shares in the company, valued at approximately $6,913,524.74. This trade represents a 38.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 63,629 shares of company stock valued at $9,223,785. 1.51% of the stock is currently owned by insiders.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.